Alexion Pharmaceuticals today announced plans to significantly expand its operations in Ireland by constructing the Company’s first ever biologics manufacturing facility outside the United States.
Planning permission is being sought for the construction of a 20,000 sq. metre facility making it one of the largest investments in healthcare in the history of Ireland.
Alexion develop life-transforming therapies for patients with severe and life-threatening ultra-rare disorders.
Since first entering Ireland in 2013, Alexion has invested €130 million in two facilities – a vial fill-finish facility in Athlone and a Global Supply Chain facility at College Park. Phase 1 of the College Park facility is expected to be operational by year-end. Approximately 560 construction workers are involved in the development of the current Athlone and College Park projects, and the planned expansion of College Park is expected to create over 800 construction jobs.
Alexion currently employs a staff of 170 and growing across its facilities in Athlone and its temporary offices in Park West Dublin.
Current job vacancies advertised with the Company include:
- Automation Engineer
- Warehouse Supervisor
- Analyst QC Chemistry
- Supervisor - Microbiology
- Instrumentation and Controls Engineer
For a full list of available job opportunities and to apply click here.
Speaking at College Park, Minister for Jobs, Enterprise and Innovation Richard Bruton TD said “Biopharma is a sector which we have specifically targeted as part of the Action Plan for Jobs, due to the large potential for employment growth which it offers Ireland, and we have taken a number of steps to support the growth of this sector in Ireland. Today’s announcement by Alexion is a huge boost for west Dublin and the whole country, and huge credit is owed to Julie and her team as well as the IDA. Employment will be provided for 1000 extra people, and the knock-on impact of this massive €450 million investment for the wider economy will be enormous. We are developing a powerful cluster of biopharma plants in Ireland which I am determined now to build on.”
The development of Athlone and Phase 1 at College Park will see approximately 300 people employed directly by Alexion by the end of 2016. If granted permission, Phase 2 of College Park is expected to take four years to complete and will create 200 jobs.
Explore Ireland’s Biopharma Sector including career videos, articles and advice from sector experts.
Source: IDA Press Release
The CareersPortal Team